About Retractable Technologies
Retractable Technologies is a publicly listed company based in Little Elm (United States) founded in 1989 by Thomas Shaw. It provides portfolio of smart syringes and needles to prevent from needle-stick injuries. The company has 227 employees. Its chief executive, as recorded, is Thomas Shaw. Retractable Technologies offers products and services including VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter. Its focus areas include Life Sciences, Drug Delivery and Safe Syringes. Its legal entity is Retractable Technologies, Inc. Its competitors include Flat Medical and SOL-Millennium.
Company details
Retractable Technologies was founded in 1989 and is headquartered in Little Elm, United States. Focus is placed on the medical device sector, where safety products are developed for healthcare applications. VanishPoint Syringes are offered in multiple sizes, gauges, and lengths, with needles retracting automatically into the barrel upon plunger depression. EasyPoint retractable needles are also included, featuring automated technology for pre-removal safety to reduce injury risks.
- Headquarters Little Elm, United States
- Employees 227
- Founders Thomas Shaw
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website retractable.com
- Social LinkedIn Facebook YouTube
- Legal Name Retractable Technologies, Inc.
- Annual Revenue$38.27 M (USD)15.78as on Dec 31, 2025
- Net Profit-$12.57 M (USD)-5.71as on Dec 31, 2025
- EBITDA-$12.45 M (USD)7.98as on Dec 31, 2025
- Latest Funding Round$27.37M (USD), Grant
Jul 2020
- Investors
- Employee Count227
Products & Services of Retractable Technologies
Retractable Technologies offers a comprehensive portfolio of products and services, including VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter.
Retractable syringe that prevents needlestick injuries during injections.
Needle designed for safe blood collection and reduced injury risk.
Specialized syringe for insulin with low dead space to minimize waste.
Tube with needle for secure blood sampling and safety features.
Catheter that ensures safe intravenous access and injury prevention.
Apps and channels of Retractable Technologies
its YouTube channel Retractable Technologies, Inc. has 389 subscribers and 9 videos.
Videos from Retractable Technologies
The most watched videos on Retractable Technologies's YouTube channel, Retractable Technologies, Inc. (389 subscribers). Click a video to play it here.
More on Retractable Technologies, Inc..
Funding Insights of Retractable Technologies
- Total Rounds 1
- Last Round Grant — $27.37M
- First Round $27.37M
(Jul 2020)
- Investors Count 1
All 1 funding rounds of Retractable Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $27.37M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Retractable Technologies
Retractable Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include USAGov.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entity focused on information and services | 2000 | usa.gov | United States |
Investor details for Retractable Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Retractable Technologies
1 people are tracked at Retractable Technologies (1 in leadership); the tracked headcount is 227.
| Name | Role | Group |
|---|---|---|
Thomas Shaw | Founder & CEO | Leadership |
Complete people profiles for Retractable Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Retractable Technologies
Retractable Technologies is a publicly listed company on the AMEX with ticker symbol RVP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date04 May 2001
- Listed onNYSE: RVP
- Listed entityRetractable Technologies, Inc.
- Exchange sectorHealth technology
- ISINUS76129W1053
- Share price$0.61 (-6.15% on the day) · 2026-10-13
- Market capitalisation$18.3M
- EPS (diluted, trailing year)$-0.12
- Volume (last session)179,570
Financials of Retractable Technologies
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $38.3M | -$12.6M | -$12.4M |
| 2024 | $33.0M | -$11.9M | -$13.5M |
| 2023 | $43.6M | -$7.0M | -$4.0M |
| 2022 | $94.8M | $5.1M | $3.8M |
| 2021 | $188.4M | $56.1M | $73.8M |
Detailed financial statements for Retractable Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Retractable Technologies
3 dated milestones of Retractable Technologies across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Retractable Technologies is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $27.4M.
Competitors of Retractable Technologies
Retractable Technologies has 2 listed competitors in our database. They include Flat Medical and SOL-Millennium.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| flatmedical.com | 2015 | Oakland, United States | Epidural injection syringes with pressure detection are manufactured. | |||
| sol-m.com | 2011 | Lawrenceville, United States | Safe injections, syringes and needles |
Detailed competitors of Retractable Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Retractable Technologies
The website of Retractable Technologies (retractable.com) receives about 5.2K visits a month.
- Monthly visits5.2K
▲ 3.9% vs previous month
Websites whose visitors overlap most with Retractable Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
axiommedicals.com | axiommedicals.com | 100% | #2,449,267 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Retractable Technologies (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Retractable Technologies
Complete news archive for Retractable Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Retractable Technologies
Retractable Technologies was founded in 1989 and raised its 1st funding round 31 years after it was founded.
Retractable Technologies is headquartered in Little Elm, United States. It is registered at Little Elm, Texas, United States.
Thomas Shaw is the CEO of Retractable Technologies, as recorded in our data. They have also founded this company.
Retractable Technologies has 227 employees.
Annual revenue of Retractable Technologies is $38.27M as on Dec 31, 2025.
Retractable Technologies was founded in 1989 and is headquartered in Little Elm, United States. Focus is placed on the medical device sector, where safety products are developed for healthcare applications. VanishPoint Syringes are offered in multiple sizes, gauges, and lengths, with needles retracting automatically into the barrel upon plunger depression. EasyPoint retractable needles are also included, featuring automated technology for pre-removal safety to reduce injury risks.
Retractable Technologies's top competitors include Flat Medical and SOL-Millennium.
Retractable Technologies offers VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter.
Yes, Retractable Technologies is publicly traded on AMEX under the ticker symbol RVP.
Retractable Technologies has 1 investor. Key investors include USAGov.
Retractable Technologies operates through Retractable Technologies, Inc..